Centogene N.V.
NASDAQ:CNTG
0.325 (USD) • At close November 14, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Revenue
| 47.541 | 47.473 | 189.923 | 128.381 | 48.78 | 40.478 | 31.689 | 27.669 |
| Cost of Revenue
| 35.931 | 27.712 | 161.765 | 86.378 | 26.005 | 19.941 | 14.939 | 12.856 |
| Gross Profit
| 11.61 | 19.761 | 28.158 | 42.003 | 22.775 | 20.537 | 16.75 | 14.813 |
| Gross Profit Ratio
| 0.244 | 0.416 | 0.148 | 0.327 | 0.467 | 0.507 | 0.529 | 0.535 |
| Reseach & Development Expenses
| 10.167 | 17.488 | 19.297 | 14.935 | 9.59 | 6.3 | 6.396 | 5.885 |
| General & Administrative Expenses
| 29.173 | 29.206 | 44.79 | 37.665 | 23.16 | 18.61 | 9.498 | 8.888 |
| Selling & Marketing Expenses
| 12.564 | 9.924 | 9.86 | 7.58 | 9.254 | 7.474 | 5.897 | 5.364 |
| SG&A
| 41.677 | 39.13 | 54.65 | 45.245 | 32.414 | 26.084 | 15.395 | 14.252 |
| Other Expenses
| 1.913 | -0.34 | -0.97 | -2.219 | 0.109 | -2.136 | 0 | 0.291 |
| Operating Expenses
| 49.931 | 56.278 | 72.977 | 57.961 | 42.113 | 30.248 | 21.28 | 19.214 |
| Operating Income
| -38.321 | -36.517 | -44.819 | -15.958 | -19.338 | -10.606 | -4.455 | -4.937 |
| Operating Income Ratio
| -0.806 | -0.769 | -0.236 | -0.124 | -0.396 | -0.262 | -0.141 | -0.178 |
| Total Other Income Expenses Net
| 3.076 | -1.823 | -4.225 | 32.634 | -1.359 | -1.937 | -1.007 | -0.741 |
| Income Before Tax
| -34.227 | -38.596 | -46.876 | -21.097 | -20.697 | -11.648 | -5.462 | -5.767 |
| Income Before Tax Ratio
| -0.72 | -0.813 | -0.247 | -0.164 | -0.424 | -0.288 | -0.172 | -0.208 |
| Income Tax Expense
| 0.281 | 0.107 | -0.024 | 0.281 | 0.158 | -0.31 | 0.014 | -0.408 |
| Net Income
| -34.804 | -38.703 | -46.852 | -21.378 | -20.855 | -11.338 | -5.476 | -5.359 |
| Net Income Ratio
| -0.732 | -0.815 | -0.247 | -0.167 | -0.428 | -0.28 | -0.173 | -0.194 |
| EPS
| -1.24 | -1.44 | -2.09 | -1.02 | -1.27 | -0.57 | -0.28 | -0.27 |
| EPS Diluted
| -1.24 | -1.44 | -2.09 | -1.02 | -1.27 | -0.57 | -0.28 | -0.27 |
| EBITDA
| -30.867 | -26.002 | -41.031 | -50.123 | -12.743 | -5.398 | -1.293 | -2.941 |
| EBITDA Ratio
| -0.649 | -0.548 | -0.124 | -0.006 | -0.261 | -0.111 | -0.04 | -0.083 |